SCHEMBL13820552

SCHEMBL13820552

c1ccc(-c2cccc(-c3c(-c4ccccc4)c4cc5c(-c6cccc(-c7ccncc7)n6)c6ccccc6c(-c6cccc(-c7ccncc7)n6)c5cc4c4ccccc34)c2)cc1

nearest known ligand 0.42

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
KMT2A Q03164 3/20 0.42
MEN1 O00255 2/20 0.42
RAB9A P51151 2/20 0.42
NOTUM Q6P988 1/20 0.40
DHODH Q02127 1/20 0.39
KDM4E B2RXH2 3/20 0.38
ALDH1A1 P00352 2/20 0.38
MAPT P10636 2/20 0.38
HPGD P15428 1/20 0.38
MAPK1 P28482 1/20 0.36
LMNA P02545 1/20 0.36
RECQL P46063 1/20 0.36
NPSR1 Q6W5P4 1/20 0.36
AR P10275 2/20 0.36
MKNK1 Q9BUB5 1/20 0.36
CDK5 Q00535 1/20 0.36
CDK5R1 Q15078 1/20 0.36
GSK3B P49841 1/20 0.35
PIK3CA P42336 1/20 0.35
CDC7 O00311 1/20 0.35

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL13820734 0.90 HSD17B1 (0.40) KMT2AMEN1RAB9ADHODHKDM4E
SCHEMBL13820676 0.90 HSD17B1 (0.40) KMT2AMEN1RAB9ADHODHKDM4E
SCHEMBL13820530 0.87 NOTUM (0.48) RAB9ANOTUMDHODHMAPTLMNA
SCHEMBL15366882 0.86 KMT2A (0.47) KMT2AMEN1RAB9ANOTUMDHODH
SCHEMBL13658712 0.85 KMT2A (0.48) KMT2AMEN1RAB9ANOTUMDHODH
SCHEMBL13820569 0.81 KDM4E (0.42) RAB9ANOTUMKDM4EALDH1A1MAPT
SCHEMBL13820372 0.81 KDM4E (0.45) KMT2AMEN1RAB9ANOTUMDHODH
SCHEMBL24662784 0.80 NOTUM (0.58) RAB9ANOTUMDHODHMAPTLMNA
SCHEMBL13820313 0.80 NOTUM (0.52) KMT2AMEN1RAB9ANOTUMKDM4E
SCHEMBL13820711 0.80 HSD17B1 (0.44) NOTUMMKNK1PIK3CAHSD17B1HSD17B2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20120286251-A1 NOVEL COMPOUND AND ORGANIC LIGHT-EMITTING DEVICE INCLUDING THE SAME SAMSUNG DISPLAY CO., LTD. (KR) 2012-11-15 US disclosed
US-20120286251-A1 NOVEL COMPOUND AND ORGANIC LIGHT-EMITTING DEVICE INCLUDING THE SAME SAMSUNG DISPLAY CO., LTD. (KR) 2012-11-15 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20120286251-A1 NOVEL COMPOUND AND ORGANIC LIGHT-EMITTING DEVICE INCLUDING THE SAME CRY1, LEF1, OR51E2 KMT2A 1307/4885MEN1 121/4885RAB9A 2345/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.